Mobidiag Extends Distribution Agreement with PerkinElmer to Offer Amplidiag® Diagnostics Products in African Countries and Israel
Mobidiag Ltd, a Finnish molecular diagnostics company, today announced the expansion of its distribution agreement with PerkinElmer’s Wallac Oy subsidiary to include distribution of the Amplidiag® product line in Israel and several countries in Africa. The Amplidiag® product line, including in vitro diagnostic tests and compatible systems for the detection of gastrointestinal infections, is now distributed in Botswana, Ghana, Ivory Coast, Kenya, Mauritius, Morocco, Mozambique, Nigeria, Rwanda, Senegal, Uganda and Israel.
“Since January 2017 Amplidiag’s product line has been available outside of Europe, and more specifically in South Africa through a distribution agreement with PerkinElmer. The relationship has been very successful since then and as a result we are extending the agreement to speed up our sales coverage in Africa and also to enter the Middle East diagnostics market. We are very pleased that PerkinElmer will continue to support us in our endeavor with its acknowledged expertise and worldwide leadership in the field of diagnostics,” said Tuomas Tenkanen, CEO at Mobidiag.
The agreement is effective immediately and covers all Amplidiag IVD tests (Amplidiag® H. pylori+ClariR, Amplidiag® Stool Parasites, Amplidiag® CarbaR+VRE, Amplidiag® C. difficile+027, Amplidiag® Bacterial GE and upcoming Amplidiag® Viral GE and Amplidiag® CarbaR+MCR) as well as the Amplidiag® Easy system.
About Amplidiag products
Amplidiag assays are innovative multiplex tests for the detection of gastrointestinal infections. They allow screening of panels of the most relevant gastrointestinal pathogens. Based on well-established real-time PCR technology, they ensure optimal performance, suitability for high-volume screening use and cost-effectiveness in mid-sized to large laboratory settings. In addition, Mobidiag allows process automation from sample extraction to PCR set-up with the Amplidiag Easy system.
About Mobidiag Ltd
Established in 2000, Mobidiag develops innovative solutions to advance the diagnosis of infectious diseases and serves the European clinical diagnostics market since 2008. Mobidiag is headquartered in Espoo, Finland.
Mobidiag addresses both high to medium volume screening with the new Amplidiag® Easy platform, bringing the Amplidiag suite further by automating the workflow from sample to results, and the upcoming Novodiag® platform & associated panels for a fully automated solution and suitable for smaller volumes and labs. Visit www.mobidiag.com .
Tuomas Tenkanen, +358 505534980
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
MASIMO16.7.2018 07:02 | pressemeddelelse
New Study Investigates the Utility of Masimo PVi® as Part of Goal-Directed Fluid Management in Patients Undergoing Colorectal Surgery
ANT-FINANCIAL16.7.2018 04:02 | pressemeddelelse
Alipay and Singapore Tourism Board join hands to boost Chinese tourist spending
KOZA-ALTIN13.7.2018 18:00 | pressemeddelelse
Koza Altin Welcomes Court’s Rejection of Akin Ipek’s Share Purchase Agreement
MINDBREEZE13.7.2018 17:29 | pressemeddelelse
Mindbreeze Positioned in the Leaders Quadrant of the Gartner’s 2018 Magic Quadrant for Insight Engines
H.I.G.-CAPITAL13.7.2018 16:08 | pressemeddelelse
H.I.G. Capital Announces the Sale of Kondor
VISA-INC.13.7.2018 11:02 | pressemeddelelse
Contactless Technology Powers Fifty Percent of Purchases at 2018 FIFA World Cup Russia™
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum